Evidence map›Paper›PMID 36800194›Full record

ArticleJAMA health forum2023

Comparison of the Pathway to Hospice Enrollment Between Medicare Advantage and Traditional Medicare.

Claire K Ankuda, Emmanuelle Belanger, Jennifer Bunker, Pedro Gozalo, Laura Keohane, David Meyers, Amal Trivedi, Joan M Teno

Open access · goldAbstract read
In one paragraph

Article in JAMA health forum, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
2.0field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Claire K AnkudaDepartment of Geriatrics and Palliative Medicine, Icahn School of Medicine at Mount Sinai, New York, New York.
Emmanuelle BelangerBrown School of Public Health, Brown University, Providence, Rhode Island.
Jennifer BunkerBrown School of Public Health, Brown University, Providence, Rhode Island.
Pedro GozaloBrown School of Public Health, Brown University, Providence, Rhode Island.
Laura KeohaneDepartment of Health Policy, Vanderbilt University Medical Center, Nashville, Tennessee.
David MeyersBrown School of Public Health, Brown University, Providence, Rhode Island.
Amal TrivediBrown School of Public Health, Brown University, Providence, Rhode Island.
Joan M TenoBrown School of Public Health, Brown University, Providence, Rhode Island.
Brown University · USIcahn School of Medicine at Mount Sinai · USVanderbilt University Medical Center · US

Funding

Residing in the Community with Dementia at the End of Life: Understanding Hospice Use and Residential SettingP30AG028741 · NIA · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI MELISSA Diane ALDRIDGE, R. Sean Morrison · 2010 to 2026
$21.9M
Health Care Use After Functional Disability: Opportunities to Improve the Care of Older AdultsK76AG064427 · NIA · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI ANKUDA, CLAIRE KATHRYN · 2020 to 2024
$1.3M
NIA NIH HHS P30 AG028741
6 · The paper itself

Abstract

Importance: Older adults in Medicare Advantage (MA) enroll in hospice at higher rates than those in traditional Medicare (TM), but it is unclear whether the pathway of care prior to hospice use differs between MA and TM. Objective: To examine the site of care prior to hospice enrollment for MA beneficiaries compared with those in TM. Design, Setting, and Participants: This population-based, retrospective cross-sectional study used Medicare claims data for decedents in calendar years 2011, 2013, 2016, and 2018 who enrolled in hospice in the last 90 days of life. Data were analyzed from February 11, 2022, to October 24, 2022. Exposures: Enrollment in MA or TM in the last month of life. Main Outcomes and Measures: The main outcome was the site of care prior to hospice enrollment, defined as hospital, nursing home, and home with or without home health, dichotomized as community vs hospital in a logistic regression model. Covariates included decedent demographics, hospice primary diagnosis, and county-level MA penetration. Differences in hospice length of stay between MA beneficiaries and TM beneficiaries were assessed using linear and logistic regression models. Results: In this study of 3 164 959 decedents, mean (SD) age was 83.1 (8.6) years, 55.8% were female, and 28.8% were enrolled in MA. Decedents in MA were more likely to enroll in hospice from a community setting than were those in TM, although the gap narrowed over time from an unadjusted 11.1% higher rate of community enrollment in MA vs TM in 2011 (50.1% vs 39.0%) to 8.1% in 2018 (46.4% vs 38.3%). In the primary adjusted analysis over the entire study period, MA enrollment was associated with an 8.09-percentage point (95% CI, 7.96-8.21 percentage points) higher rate of hospice enrollment from the community vs all other sites. This association remained in multiple sensitivity analyses to account for potential differences in the populations enrolled in MA vs TM. The mean overall hospice length of stay was 0.29 days (95% CI, 0.24-0.34 days) longer for MA decedents compared with TM decedents. Conclusions and Relevance: Compared with TM beneficiaries, those in MA were more likely to enroll in hospice from community settings vs following inpatient stays. However, hospice length of stay was not substantially different between MA and TM. Further research is needed to understand how MA plans influence hospice use and the direct association with quality of end-of-life care as reported by older adults and their families.

Indexed as

Hospice CareHospicesMedicare Part CAgedAged, 80 and overCross-Sectional StudiesFemaleHumansMaleRetrospective StudiesUnited States

Identifiers

PMID36800194
PMCPMC9938424
OpenAlexW4321169781

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.